Bnp Paribas Asset Management Holding S.A. Alkermes Plc. Transaction History

Bnp Paribas Asset Management Holding S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$38.6 - $46.12 $11 Million - $13.2 Million	-285,470 Closed	0 $0
Q2 2018 Aug 01, 2018	SELL	$40.56 - $51.36 $11 Million - $14 Million	-272,198 Reduced 48.81%	285,470 $11.8 Million
Q1 2018 May 07, 2018	SELL	$53.61 - $67.26 $4.53 Million - $5.68 Million	-84,436 Reduced 13.15%	557,668 $32.3 Million
Q4 2017 Feb 01, 2018	SELL	$47.69 - $55.39 $5.58 Million - $6.48 Million	-116,942 Reduced 15.41%	642,104 $35.1 Million
Q3 2017 Nov 02, 2017	BUY	$49.16 - $54.45 $37.3 Million - $41.3 Million	759,046	759,046 $38.6 Million

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.84B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.